Muramidase in myeloproliferative disorde
โ
Arthur T. Skarin; Yoshiro Matsuo; William C. Moloney
๐
Article
๐
1972
๐
John Wiley and Sons
๐
English
โ 664 KB
During serial studies of serum muramidase activity (SMA) over a 4-year period on 168 patients with leukemia and myeloproliferative disorders (MPD) eight p a t i e n w n e with polycythemia Vera (PCV), one with agnogenic myeloid metaplasia, three with atypical myeloid metaplasia, and three with chron